The smaller and more pre-term a baby is at birth, the greater their chance of having retinopathy of prematurity (ROP), an eye disorder that can lead to vision loss. But most babies who are born ...

Background: The Early Treatment for Retinopathy of Prematurity study (ETROP), published in 2003, established new guidelines for treatment of retinopathy of prematurity (ROP) and demonstrated ...

Retinopathy of prematurity (ROP) is a major cause of vision impairment in preterm infants, particularly those born weighing ≤1,250 g. Anemia is commonly observed in these infants, with nearly 90 ...

Retinopathy of Prematurity (ROP) also known as Retrolental Fibroplasia (RLF) and Terry’s Syndrome is an eye disease found in premature infants. It affects the retina, which senses light and ...

Mydriatic microdrops during retinopathy of prematurity (ROP) screening were noninferior to standard drops, which have been associated with cardiorespiratory and gastrointestinal adverse events ...

Every year, an alarming number of babies are born prematurely across the globe, encountering a host of health issues and ...

Lurie Children's Hospital of Chicago promises to spare many premature infants from undergoing invasive eye exams to detect retinopathy of prematurity (ROP), the most common cause of preventable ...

Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP). While the relationship between anemia and ROP risk remains complex, recent ...

Credit: Getty Images. The approval was based on data from the phase 3 BUTTERFLEYE and FIREFLEYE trials. The Food and Drug Administration (FDA) has approved Eylea ® (aflibercept) for the treatment ...